-+ 0.00%
-+ 0.00%
-+ 0.00%

Ernexa Therapeutics posts on-demand video webcast of investor presentation

PUBT·08/27/2026 13:02:52
Listen to the news
Ernexa Therapeutics posts on-demand video webcast of investor presentation
  • Ernexa Therapeutics published an on-demand video webcast presentation from a Virtual Investor “Why Now” conference. Link
  • Presentation outlines a planned shift to a clinical-stage profile, with ERNA-101 moving toward an IND filing.
  • Webcast highlights plans to start a first-in-human Phase 1 study for ERNA-101.
  • Materials discuss ERNA-101’s off-the-shelf iMSC platform, preclinical ovarian cancer data, manufacturing, regulatory, clinical execution.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ernexa Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608270901PRIMZONEFULLFEED9816888) on August 27, 2026, and is solely responsible for the information contained therein.